Genenta Announces Pricing of $15.0 Million Registered
MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) — Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced that it has entered into a securities purchase agreement with institutional investors to purchase 4,285,715 American Depositary Shares (“ADSs”) at an offering price of $3.50 per ADS, for gross proceeds of approximately $15.0 million, before … Read more